Related Experiment Videos
RNF213-TRAF2 interaction enhances inflammatory responses via NF-κB activation in moyamoya disease
Mitsutaka Yasuda1,2, Kaoru Murakami1, Jing-Jing Jiang1,3
1Division of Molecular Psychoimmunology, Institute for Genetic Medicine, Graduate School of Medicine, Hokkaido University, Sapporo 060-0815, Japan.
Abstract:
Moyamoya disease (MMD) is a cerebrovascular disorder that predominantly affects East Asian populations. It is characterized by progressive stenosis or occlusion of terminal internal carotid arteries. Although inflammatory and autoimmune responses have been implicated in MMD pathogenesis, the precise molecular mechanisms underlying the disease remain poorly understood. RNF213, a key susceptibility gene for MMD, has been linked to inflammatory signaling; however, its role in NF-κB-driven inflammation remains unclear. Here, we identify RNF213 as a critical regulator of the IL-6 amplifier (IL6-Amp), a mechanism that enhances NF-κB-mediated inflammation in the presence of IL-6-STAT3 in non-immune cells. RNF213 knockdown reduced IL-6 expression in H4 cells, a model for IL6-Amp induction via tumor necrosis factor (TNF)-α and IL-6 co-stimulation, selectively suppressing NF-κB target genes. In vivo, RNF213 depletion attenuated inflammation in an NF-κB-dependent imiquimod-induced ear swelling model. The MMD-associated RNF213 p.R4810K variant enhanced NF-κB activation by strengthening the interaction between RNF213 and TRAF2, a key adaptor in TNF-α-NF-κB signaling. Consistent with these findings, histopathological analysis of superficial temporal arteries from MMD patients revealed genotype-dependent IL6-Amp activation, with pronounced phosphorylation of NF-κB p65 and STAT3 in homozygous carriers. In contrast, heterozygous and wild-type vessels showed minimal basal activation, but in vitro stimulation of arachnoid cells from a heterozygous patient recapitulated IL6-Amp responsiveness. Collectively, these findings establish RNF213 as a pivotal regulator of NF-κB-driven inflammation and suggest that the p.R4810K variant amplifies inflammatory signaling, thereby contributing to MMD pathogenesis. This study not only advances our understanding of MMD pathophysiology but also highlights potential therapeutic strategies targeting inflammation.
Insights
RNF213 regulates inflammation in Moyamoya disease (MMD) by controlling the IL-6 amplifier. The MMD-associated RNF213 variant enhances this pathway, contributing to disease pathogenesis and suggesting new therapeutic targets.
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- Moyamoya disease (MMD) is a cerebrovascular disorder with unknown molecular mechanisms, though inflammation is implicated.
- RNF213 is a key MMD susceptibility gene, but its role in NF-κB inflammation is unclear.
Purpose of the Study:
- To investigate the role of RNF213 in NF-κB-driven inflammation and its contribution to MMD pathogenesis.
- To elucidate the function of the MMD-associated RNF213 p.R4810K variant in inflammatory signaling.
Main Methods:
- Utilized cell culture models (H4 cells, arachnoid cells) to study IL-6 amplifier (IL6-Amp) induction and NF-κB signaling.
- Employed in vivo models (imiquimod-induced ear swelling) to assess RNF213's role in inflammation.
- Analyzed patient-derived superficial temporal artery tissues for genotype-dependent inflammatory markers.
Main Results:
- RNF213 knockdown reduced IL-6 expression and NF-κB target genes in vitro.
- RNF213 depletion attenuated inflammation in vivo.
- The MMD-associated RNF213 p.R4810K variant enhanced NF-κB activation by strengthening RNF213-TRAF2 interaction.
- MMD patient arteries showed genotype-dependent IL6-Amp activation, with increased NF-κB p65 and STAT3 phosphorylation in homozygous carriers.
Conclusions:
- RNF213 is a critical regulator of NF-κB-driven inflammation via the IL6-Amp.
- The MMD-associated RNF213 variant amplifies inflammatory signaling, contributing to MMD pathogenesis.
- This study identifies potential therapeutic targets for MMD by focusing on inflammation modulation.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
NF-kB-dependent Signaling Pathway
MAPK Signaling Cascades
Inflammatory Response I: Vascular and Cellular
Nitric Oxide Signaling Pathway